Cidara Therapeutics (CDTX) Competitors $23.22 +0.71 (+3.15%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDTX vs. CRGX, STOK, ALT, EXAI, TERN, ORIC, VECT, PHAT, TRML, and PROKShould you be buying Cidara Therapeutics stock or one of its competitors? The main competitors of Cidara Therapeutics include CARGO Therapeutics (CRGX), Stoke Therapeutics (STOK), Altimmune (ALT), Exscientia (EXAI), Terns Pharmaceuticals (TERN), ORIC Pharmaceuticals (ORIC), VectivBio (VECT), Phathom Pharmaceuticals (PHAT), Tourmaline Bio (TRML), and ProKidney (PROK). These companies are all part of the "pharmaceutical products" industry. Cidara Therapeutics vs. CARGO Therapeutics Stoke Therapeutics Altimmune Exscientia Terns Pharmaceuticals ORIC Pharmaceuticals VectivBio Phathom Pharmaceuticals Tourmaline Bio ProKidney CARGO Therapeutics (NASDAQ:CRGX) and Cidara Therapeutics (NASDAQ:CDTX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Which has better valuation & earnings, CRGX or CDTX? Cidara Therapeutics has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Cidara Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.50Cidara Therapeutics$44.65M3.66-$22.93M-$25.52-0.91 Is CRGX or CDTX more profitable? CARGO Therapeutics has a net margin of 0.00% compared to Cidara Therapeutics' net margin of -289.05%. CARGO Therapeutics' return on equity of -38.16% beat Cidara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -38.16% -33.94% Cidara Therapeutics -289.05%-69.64%-33.73% Do analysts rate CRGX or CDTX? CARGO Therapeutics presently has a consensus price target of $31.80, indicating a potential upside of 113.42%. Cidara Therapeutics has a consensus price target of $32.20, indicating a potential upside of 38.67%. Given CARGO Therapeutics' higher possible upside, equities analysts plainly believe CARGO Therapeutics is more favorable than Cidara Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Cidara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Do insiders & institutionals believe in CRGX or CDTX? 93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 35.8% of Cidara Therapeutics shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by insiders. Comparatively, 7.6% of Cidara Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor CRGX or CDTX? In the previous week, CARGO Therapeutics had 1 more articles in the media than Cidara Therapeutics. MarketBeat recorded 4 mentions for CARGO Therapeutics and 3 mentions for Cidara Therapeutics. Cidara Therapeutics' average media sentiment score of 0.49 beat CARGO Therapeutics' score of 0.39 indicating that Cidara Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CARGO Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cidara Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor CRGX or CDTX? Cidara Therapeutics received 435 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 70.27% of users gave Cidara Therapeutics an outperform vote. CompanyUnderperformOutperformCARGO TherapeuticsOutperform Votes14100.00% Underperform VotesNo VotesCidara TherapeuticsOutperform Votes44970.27% Underperform Votes19029.73% SummaryCidara Therapeutics beats CARGO Therapeutics on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDTX vs. The Competition Export to ExcelMetricCidara TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$163.63M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio-0.9146.7389.8217.18Price / Sales3.66415.011,116.21116.95Price / CashN/A182.1042.8937.86Price / Book-12.763.894.784.78Net Income-$22.93M-$42.21M$120.23M$225.60M7 Day Performance1.49%-2.15%-1.92%-1.23%1 Month Performance27.65%4.20%11.49%3.36%1 Year Performance57.34%18.39%30.57%16.60% Cidara Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDTXCidara Therapeutics3.6832 of 5 stars$23.22+3.2%$32.20+38.7%+54.8%$163.63M$44.65M-0.9190High Trading VolumeCRGXCARGO Therapeutics1.4622 of 5 stars$14.17+3.1%$31.80+124.4%-20.0%$652.22MN/A-3.23116STOKStoke Therapeutics4.194 of 5 stars$12.31+2.1%$20.83+69.2%+140.1%$652.06M$8.78M-5.74100Analyst ForecastNews CoverageGap DownALTAltimmune1.9536 of 5 stars$9.05+0.2%$20.00+121.0%+3.4%$643.68M$52,000.00-5.8350News CoveragePositive NewsEXAIExscientia1.0615 of 5 stars$4.84+3.2%$7.00+44.6%-20.8%$632.93M$25.60M-3.21280High Trading VolumeTERNTerns Pharmaceuticals4.2412 of 5 stars$6.94+3.1%$18.30+163.7%-6.8%$589.48M$1M-5.7040Positive NewsGap DownORICORIC Pharmaceuticals3.6849 of 5 stars$8.25-3.2%$18.29+121.6%-3.8%$582.20MN/A-4.6880Insider TradeGap DownVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030PHATPhathom Pharmaceuticals2.9962 of 5 stars$8.37+6.1%$23.00+174.8%-9.3%$572.34M$680,000.00-1.48110TRMLTourmaline Bio2.4402 of 5 stars$22.14+1.5%$54.00+143.9%+8.7%$567.74MN/A-7.7344PROKProKidney2.0368 of 5 stars$1.91+6.1%$4.50+136.2%-15.6%$555.62MN/A-3.553Gap Down Related Companies and Tools Related Companies CARGO Therapeutics Competitors Stoke Therapeutics Competitors Altimmune Competitors Exscientia Competitors Terns Pharmaceuticals Competitors ORIC Pharmaceuticals Competitors VectivBio Competitors Phathom Pharmaceuticals Competitors Tourmaline Bio Competitors ProKidney Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDTX Stock Alerts